Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion
Not Applicable
Completed
- Conditions
- General AnesthesiaBreast Disease
- Interventions
- Drug: use of rocuronium when the LMA is inserted
- Registration Number
- NCT01035021
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
The aim of this study is to evaluate the success rate, insertion time and complication depending on the use of neuromuscular blocking agent when inserting the laryngeal mask airway (LMA).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 160
Inclusion Criteria
- 18-70 year
- american society of anesthesiologist status 1-2
- elective general anesthesia
Exclusion Criteria
- known or predicted difficult airway
- recent sore throat
- mouth opening less than 2.5 cm
- at risk of aspiration
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description group N use of rocuronium when the LMA is inserted Anesthesia is induced with propofol and remifentanil and LMA is inserted by the standard technique according to eht manufacturer's instruction. Rocuronium is administered for the operation. group R use of rocuronium when the LMA is inserted Anesthesia is induced with a propofol and remifentanil and rocuronium 0.06 mg/kg is injected. Insertion of LMA is performed by the standard technique according to the manufacturer's instruction.
- Primary Outcome Measures
Name Time Method success rate and insertion time when laryngeal mask airway is inserted
- Secondary Outcome Measures
Name Time Method complication after the remove of LMA - bleeding, sore throat 1 hour after the LMA is removed
Trial Locations
- Locations (1)
Seoul National University Bundang Hospital
🇰🇷Seongnam-si, Gyeonggi-do, Korea, Republic of